A MACHINE LEARNING APPROACH APPLIED TO GYNECOLOGICAL ULTRASOUND TO PREDICT PROGRESSION-FREE SURVIVAL IN OVARIAN CANCER PATIENTS

被引：0
|
作者：
Arezzo, F. [1 ]
Loizzi, V. [1 ]
Santarsiero, C. M. [1 ]
Cazzato, G. [2 ]
Cataldo, V. [1 ]
Mongelli, M. [1 ]
Cicinelli, E. [1 ]
Cormio, G. [1 ]
机构：
[1] Univ Bari, Obstet & Gynecol Unit, Bari, Italy
[2] Univ Bari, Pathol Sect, Bari, Italy
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2021年 / 31卷
关键词：
D O I：
10.1136/ijgc-2021-ESGO.107
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
954
引用
收藏
页码：A70 / A70
页数：1
相关论文
共 50 条
  • [41] Atezolizumab does not improve progression-free survival in patients with recurrent platinum-sensitive ovarian cancer
    Gotlieb, Walter H.
    Tzur, Yossi
    GYNECOLOGY AND PELVIC MEDICINE, 2024, 7
  • [42] Body weight changes in patients undergoing chemotherapy for ovarian cancer influence progression-free and overall survival
    Marcin Mardas
    Marta Stelmach-Mardas
    Radosław Madry
    Supportive Care in Cancer, 2017, 25 : 795 - 800
  • [43] FIRST-TO-SECOND PROGRESSION-FREE SURVIVAL RATIO AS A PREDICTOR FOR OVERALL SURVIVAL IN OVARIAN CANCER
    Salman, L.
    Gandelsman, E.
    Romano, A.
    Sabah, G.
    Jakobson-Setton, A.
    Borovich, A.
    Yeoshoua, E.
    Eitan, R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A135 - A136
  • [44] Body weight changes in patients undergoing chemotherapy for ovarian cancer influence progression-free and overall survival
    Mardas, Marcin
    Stelmach-Mardas, Marta
    Madry, Radoslaw
    SUPPORTIVE CARE IN CANCER, 2017, 25 (03) : 795 - 800
  • [45] DIFFERENCES IN CORRELATION OF PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL BY CLINICAL VARIABLES IN EPITHELIAL OVARIAN CANCER
    Paik, E. S.
    Jeong, S. Y.
    Kim, M. S.
    Kim, J. H.
    Kim, T. J.
    Lee, J. W.
    Kim, B. G.
    Bae, D. S.
    Choi, C. H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 717 - 717
  • [46] Prior oral contraceptive use in ovarian cancer patients: assessing associations with overall and progression-free survival
    Aminah Jatoi
    Nathan R. Foster
    Kimberly R. Kalli
    Robert A. Vierkant
    Zhiying Zhang
    Melissa C. Larson
    Brooke Fridley
    Ellen L. Goode
    BMC Cancer, 15
  • [47] Prior oral contraceptive use in ovarian cancer patients: assessing associations with overall and progression-free survival
    Jatoi, Aminah
    Foster, Nathan R.
    Kalli, Kimberly R.
    Vierkant, Robert A.
    Zhang, Zhiying
    Larson, Melissa C.
    Fridley, Brooke
    Goode, Ellen L.
    BMC CANCER, 2015, 15
  • [48] Bevacizumab and improvement of progression-free survival (PFS) for patients with the mesenchymal molecular subtype of ovarian cancer.
    Winterhoff, Boris J. N.
    Kommoss, Stefan
    Oberg, Ann L.
    Wang, Chen
    Riska, Shaun M.
    Konecny, Gottfried E.
    Fan, Jian-Bing
    Shridhar, Viji
    Goode, Ellen L.
    Kommoss, Friedrich
    Du Bois, Andreas
    Hilpert, Felix
    Chien, Jeremy
    Embleton, Andrew Christopher
    Parmar, Mahesh
    Kaplan, Richard S.
    Perren, Timothy
    Hartmann, Lynn C.
    Pfisterer, Jacobus
    Dowdy, Sean Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [49] DIFFERENCES IN CORRELATION OF PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL BY CLINICAL VARIABLES IN EPITHELIAL OVARIAN CANCER
    Paik, E. S.
    Kang, M.
    Lee, J. H.
    Kang, J. H.
    Jeong, S. Y.
    Kim, M. S.
    Lee, Y-Y
    Kim, T-J
    Lee, J-W
    Kim, B-G
    Bae, D-S
    Seo, J.
    Choi, C. H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A504 - A505
  • [50] Pharmacogenetic score predicts overall survival, progression-free survival and platinum sensitivity in ovarian cancer
    Gagno, Sara
    Bartoletti, Michele
    Romualdi, Chiara
    Poletto, Elena
    Scalone, Simona
    Sorio, Roberto
    Zanchetta, Martina
    De Mattia, Elena
    Roncato, Rossana
    Cecchin, Erika
    Giorda, Giorgio
    Toffoli, Giuseppe
    PHARMACOGENOMICS, 2020, 21 (14) : 995 - 1010
12345